Results for L. donovani glycogen synthase kinase-3 short

Publications & Outputs

1. 6-Br-5methylindirubin-3′oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: Exploitation of GSK-3 for treating leishmaniasis

   Xingi, E., Smirlis, D., Myrianthopoulos, V., Prokopios, M., Grant, K., Meijer, L., Mikros, E., Skaltsounis, A.-L. & Soteriadou, K., 10/2009, In: International Journal for Parasitology. 39, 12, p. 1289-1303 15 p.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review